Regeneron Pharmaceuticals (REGN) Property, Plant & Equipment (Net) Growth (5y) (2014 - 2026)

Regeneron Pharmaceuticals (REGN) Property, Plant & Equipment (Net) Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Alnylam Pharmaceuticals 37.29 Bn 34.28 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.05%
Dec 31, 2025 9.71%
Sep 30, 2025 9.77%
Jun 30, 2025 9.81%
Mar 31, 2025 9.78%
Dec 31, 2024 9.74%
Sep 30, 2024 9.88%
Jun 30, 2024 9.98%
Mar 31, 2024 10.09%
Dec 31, 2023 9.99%
Sep 30, 2023 9.68%
Jun 30, 2023 9.77%
Mar 31, 2023 10.14%
Dec 31, 2022 9.79%
Sep 30, 2022 10.25%
Jun 30, 2022 9.97%
Mar 31, 2022 9.33%
Dec 31, 2021 10.82%
Sep 30, 2021 12.65%
Jun 30, 2021 13.63%